EyePoint Inc
EYPT
84 hedge funds and large institutions have $238M invested in EyePoint Inc in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 8 closing their positions.
759% more call options, than puts
Call options by funds: $1.35M | Put options by funds: $157K
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
12% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 26
2% more funds holding
Funds holding: 82 → 84 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.73% less ownership
Funds ownership: 89.43% → 88.7% (-0.73%)
36% less capital invested
Capital invested by funds: $370M → $238M (-$132M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$2.15M |
| 2 |
Millennium Management
New York
|
+$1.89M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.88M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.31M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$5.15M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.32M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.83M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.59M |
| 5 |
D.E. Shaw & Co
New York
|
-$500K |
EYPT Hedge Fund Activity: Q2 2022 in Review
84 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in EyePoint Inc (EYPT) for Q2 2022, worth a combined $238M — down 36% from $370M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new EYPT positions and 8 closed out — a net gain of 3 holders — while 29 added to existing stakes and 26 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $2.15M. The largest seller was Janus Henderson Group, cutting an estimated $5.15M.
- 84 institutional investors held EyePoint Inc (EYPT) as of Q2 2022, up from 82 in Q1 2022.
- Funds reported $238M of EyePoint Inc stock for Q2 2022, down 36% quarter-over-quarter.
- 11 funds opened new EyePoint Inc positions in Q2 2022 and 8 closed out, a net change of +3 holders.
- The largest EyePoint Inc buyer in Q2 2022 was OrbiMed, an estimated $2.15M added.
- The largest EyePoint Inc seller in Q2 2022 was Janus Henderson Group, an estimated $5.15M sold.
Based on aggregated 13F filings for Q2 2022.